Ken Griffin Outset Medical, Inc. Call Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$1.94 - $4.61 $3,298 - $7,837	1,700 Added 2.68%	65,100 $250,000
Q1 2024 May 15, 2024	BUY	$1.99 - $5.64 $106,863 - $302,868	53,700 Added 553.61%	63,400 $140,000
Q4 2023 Feb 14, 2024	SELL	$3.07 - $10.25 $37,761 - $126,075	-12,300 Reduced 55.91%	9,700 $52,000
Q3 2023 Nov 14, 2023	SELL	$10.52 - $20.68 $29,456 - $57,904	-2,800 Reduced 11.29%	22,000 $239,000
Q2 2023 Aug 14, 2023	BUY	$17.18 - $23.76 $352,190 - $487,080	20,500 Added 476.74%	24,800 $542,000
Q1 2023 May 15, 2023	SELL	$18.25 - $30.26 $113,150 - $187,612	-6,200 Reduced 59.05%	4,300 $79,000
Q4 2022 Feb 14, 2023	BUY	$12.36 - $26.41 $129,780 - $277,305	10,500 New	10,500 $271,000

121

37.6M

65.1K

91.3K

Ticker OM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 48,007,300
Market Cap $29.8M
Description
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was ...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.